Tiejun Tang B&W.jpg

Tiejun Tang

Partner Wanhuida Intellectual Property

Contact

email

Published by this author:

Sponsored content

Sponsored by Wanhuida Intellectual Property

China’s judicial landscape on infringement assessment over offering to sell a patented drug

Tiejun Tang, Yuming Wang, and Jianhui Li of Wanhuida Intellectual Property discuss the evolving landscape in China around ‘offering for sale’, with reference to a high-profile Supreme People’s Court case involving a patented drug

Tiejun Tang, December 13, 2022